Medicine for treating mammary gland hyperplasia and preparation method of medicine

Abstract

The invention discloses a medicine for treating mammary gland hyperplasia and a preparation method of the medicine, and relates to medicines for treating mammary gland hyperplasia. The medicine consists of the following raw material medicines in parts by weight: 20-30 parts of angelica sinensis, 20-30 parts of ligusticum wallichii, 20-30 parts of roots of common peony, 20-30 parts of salvia miltiorrhiza, 15-25 parts of peach kernels, 20-30 parts of rhizoma sparganii, 20-30 parts of curcuma zedoary, 20-25 parts of rhizoma corydalis, 15-25 parts of frankincense, 15-25 parts of myth, 15-25 parts of rhizoma cyperi, 5-15 parts of pangolin, 15-25 parts of dear horn pieces, 5-15 parts of rhizoma typhonii, 15-25 parts of ardisia mamillata, 15-25 parts of pinecone, 15-25 parts of ardisia crenata, 15-25 parts of loofah sponge, 15-25 parts of tangerine seeds, 15-25 parts of radix angelicae, 15-25 parts of semen brassicae, 15-25 parts of pinellia ternate, 15-25 parts of dysosma versipellis, 15-25 parts of Chinese violet, 15-25 parts of lonicera japonica, 35-45 parts of dandelion, 5-15 parts of codonopsis pilosula, 5-15 parts of astragalus membranaceus and 1-5 parts of as arum. By adopting the medicine, the purposes of activating blood and removing stasis, clearing and activating the channels and collaterals, relieving swelling and stopping pain, warming to dredge channels and remove stasis and eliminating lumps can be achieved, and the treatment effects of treating diseases from outside can be achieved as livers and intestines and stomachs are not damaged as the medicine is used externally.

Description

technical field [0001] The invention relates to a medicine for treating mammary gland hyperplasia, in particular to a medicine for treating mammary gland hyperplasia and a preparation method thereof. Background technique [0002] It is well known that mammary gland hyperplasia is one of common and frequently-occurring diseases in adult women, and about 50-60% of women of childbearing age have mammary gland hyperplasia in various degrees, mostly in women aged 20-45, and the peak of incidence is 35-40 years old; The characteristics are: the hyperplasia of mammary gland components shows abnormalities in structure, quantity and tissue morphology, leading to physiological hyperplasia and incomplete involution of normal mammary gland lobules, forming disorder of mammary gland normal structure. Degenerative disease and progressive connective tissue growth. The main cause of the disease is that the level of estrogen secreted by the ovary is too high, the corpus luteum progesterone ...

AI Technical Summary

Problems solved by technology

There are mainly the following problems: 1. Some people think that hyperplasia of mammary glands does not need to be treated. Just stop the drug; 3. There are still some people who are treated with drugs, the cost is high, the course of treatment is long, and they are easy to damage the stomach, liver and other factors, which restricts adherence to treatment; 4. Patients with breast hyperplasia masses, nodules, fibroids, and cysts, Most of the hospitals mainly use surgical resection, which is painful, leaves scars, and has a high recurrence rate; therefore, the above factors will eventually lead to the aggravation of mammary gland hyperplasia and the increase in the incidence of breast cancer; a large number of epidemiological studies have found that mammary gland hyperplasia The benign breast disease is one of the risk factors with a relatively high relative risk of breast cancer; extensive clinical epidemiological research has been done on the risk factors of breast cancer at home and abroad, and it is believed that hyperplasia of the breast, especially atypical hyperplasia, is the most important. risk factors, so the treatment of mammary gland hyperplasia is the pre-change treatment to prevent early breast cancer